The World Health Organization identified schizophrenia as one of the world’s 20 leading causes of disability. The presentation covers the impact of schizophrenia on patients and their caregivers, and its prevalence across different global regions. This slide deck explores the epidemiology and burden of schizophrenia and includes illustrations of the economic burden of the illness.

This slide deck has been developed in collaboration with the former Lundbeck International Neuroscience Foundation.

Index for
slide deck

Title

Epidemiology and Burden
Epidemiology and Burden
file_download Download slide in HQ

Epidemiology and Burden

Global Impact of Schizophrenia
Global Impact of Schizophrenia

The World Health Organization identified schizophrenia as 1 of the 20 leading causes of disability in the world in 2004.[The global burden of disease, 2004]

The same report estimated that the worldwide prevalence was more than 21 million people in 2016.[WHO, 2016]

Estimat…

file_download Download slide in HQ
The morbid risk of schizophrenia increases in relation to the percentage of genes shared with an affected individual
The morbid risk of schizophrenia increases in relation to the percentage of genes shared with an affected individual
file_download Download slide in HQ
The negative impact of schizophrenia on patients and their caregivers affects many aspects of life
The negative impact of schizophrenia on patients and their caregivers affects many aspects of life

Key message: Schizophrenia negatively impacts many different aspects of the lives of both patients and their caregivers (e.g. economic, physical health, social aspects).

Background

  • A community survey that included 697 caregivers and 439 patients with schizophrenia ident…

file_download Download slide in HQ
Caregivers of patients with schizophrenia can experience negative changes in their own quality of life
Caregivers of patients with schizophrenia can experience negative changes in their own quality of life

Key message: Decreases in the quality of life of caregivers may be associated with the burden of being a caregiver, lack of social support, course of the disease, and problems with family relationships.

Background[Caqueo-Urízar et al., 2009]

  • Literature review of 37 studi…
file_download Download slide in HQ
Inability to function in everyday settings contributes to the high cost of schizophrenia
Inability to function in everyday settings contributes to the high cost of schizophrenia

Key message: Inability of patients to function in everyday settings contributes to the high cost of schizophrenia (both direct costs from caring for patients, and indirect costs from lost employment).

Background

  • Schizophrenia causes a high degree of disability. In the g…
file_download Download slide in HQ
Schizophrenia One-Year Incidence Rates From Selected World Studies
Schizophrenia One-Year Incidence Rates From Selected World Studies

Review as stated on slide

file_download Download slide in HQ
Epidemiology of Schizophrenia in the United States
Epidemiology of Schizophrenia in the United States

The 1-year prevalence of schizophrenia in the United States was estimated to be 1.1% of the adult population.[Regier et al., 1993]

37 Population-based studies from 25 countries that reported primary data on deaths in people with schizophrenia were examined.[Saha et al., 2…

file_download Download slide in HQ
Prevalence of Schizophrenia in Asia
Prevalence of Schizophrenia in Asia

Taiwan: A random population of subjects from the National Health Insurance database was used to identify members with ≥1 claim for a principal diagnosis of schizophrenia.[Chien et al., 2004]

China: A random population of subjects from Xinjin County were interviewed face t…

file_download Download slide in HQ
Epidemiology of Schizophrenia in Europe
Epidemiology of Schizophrenia in Europe

Review as stated on slide

file_download Download slide in HQ
Epidemiology of Schizophrenia in Canada
Epidemiology of Schizophrenia in Canada

Vanasse and colleagues examined the lifetime prevalence of patients with schizophrenia in Quebec from 1996 to 2006 using public health plan databases. Patients were identified with a hospital discharge or physician claim for schizophrenia.[Vanasse et al., 2012]

Goldner et…

file_download Download slide in HQ

Related content

image Image
Parkinson’s Disease and Braak stages

The Braak staging scheme is a valuable model for conceptualizing PD progression and categorizes PD into stages of neuropathological changes.

11.04.2024 Parkinson’s Disease
Unmet Medical Needs in Bipolar Disorder and The Role of Clinicians in Addressing Them play_circle Video play_circle
Unmet Medical Needs in Bipolar Disorder and The Role of Clinicians in Addressing Them

Professor Christoph Correll discusses the complexities of bipolar disorder, shedding light on the real-world challenges in treatment, the critical role of clinicians, and the necessity of patient-centric approaches in psychiatry.

06.03.2024 Mental Health
The Heterogeneity of Bipolar Disorder: From Clinical Observations to Precision Psychiatry play_circle Video play_circle
The Heterogeneity of Bipolar Disorder: From Clinical Observations to Precision Psychiatry

Bipolar disorder is a chronic and highly debilitating mental disorder characterized by recurrent mood episodes. A major challenge is its heterogeneous clinical presentation with diverse comorbidities and symptomatology.

06.03.2024 Mental Health